Supersalud Intensifies Crackdown on Medication Delays and Health Access Barriers in Cali

Patients in Cali are facing significant hurdles in accessing essential medications, prompting the Superintendencia Nacional de Salud (Supersalud) to launch an aggressive intervention. Under the “Plan de Choque de Medicamentos” (Medication Shock Plan), the national health watchdog is conducting on-site inspections of pharmaceutical managers and dispensing points to eliminate administrative barriers and ensure treatment continuity.

Closing the Gap Between Inventory and Access

The recent intervention in Cali, led by National Health Superintendent Daniel Quintero Calle, focused on verifying actual inventory levels against what is reported to patients. The findings were stark: in several instances, medications were physically present in the stock but were reported as “pending” to the users.

“Lo que encontramos es que a muchas personas les dicen que no están las medicinas y cuando vamos al stock encontramos que sí están,” stated Quintero. He emphasized that the Superintendency is conducting real inspection, surveillance, and control over EPS, pharmaceutical managers, and providers to rectify these discrepancies.

Operational Failures and Platform Issues

Beyond simple inventory errors, Supersalud identified deeper systemic failures. The agency found that medications were frequently missing from digital registration systems, which directly caused delays in delivery. This lack of digital synchronization creates a barrier that prevents patients from receiving timely care.

The agency’s current focus includes:

• Delivery Timelines: Verifying the actual time it takes for a patient to receive a drug versus the reported time.
• Real-Time Inventory: Contrasting pending reports with physical stock.
• Platform Management: Identifying and fixing glitches in the systems used to manage deliveries.

The Human Cost: Rare Diseases and Oncological Care

The impact of these failures is most acute for the most vulnerable patients. During the inspection, Supersalud met with the Colectivo 5 de mayo, a group representing families of patients with oncological, rare, and orphan diseases. These caregivers reported severe interruptions in therapeutic continuity and the outright denial of required services.

In response to these grievances, Superintendent Quintero announced the development of a specialized follow-up and attention protocol. This mechanism is intended to provide a fast-track response to urgent cases, with the goal of scaling this protocol to serve as a model for the rest of the country.

Financial Friction: The Role of EPS Payments

The crisis in medication delivery isn’t solely an inventory problem; it’s also a financial one. Supersalud is currently auditing the payment processes between Entidades Promotoras de Salud (EPS) and their providers.

A critical six-hour meeting with Nueva EPS revealed that debts to providers are often not caused by a lack of funds, but by a lack of automation. Quintero noted that the absence of automated systems has slowed down the payment protocols, creating a ripple effect that eventually impacts the patient at the pharmacy counter.

By the Numbers: Health Claims in Valle del Cauca

The scale of the dissatisfaction in the region is reflected in the official data. The Valle del Cauca department is currently managing 16,356 open health claims. The primary drivers of these complaints are the denial of medications, delays in scheduling appointments, and a general lack of timely care.

Looking Ahead

Supersalud has made it clear that the inspections in Cali are not isolated events. The agency intends to maintain permanent surveillance over the commitments made by EPS and pharmaceutical managers. Administrative sanctions will be applied to any entity that fails to meet the agreed-upon improvements in medication delivery and system automation.